Vanguard Capital Wealth Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Vanguard Capital Wealth Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,778	Closed	-$220K	–	119
2018 Q4	$220K	Buy	+1,778	New	+$243K	0.33%	89

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Vanguard Capital Wealth Advisors's FBT Position: Q1 2019 in Review

Vanguard Capital Wealth Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2019, closing a stake of 1,778 shares — an estimated $220K sold.

Vanguard Capital Wealth Advisors first reported a position in FBT in Q4 2018 and held it in 1 quarter. The position peaked at $220K in Q4 2018. 227 funds tracked by Wall St. Rank hold FBT as of Q1 2019.

Vanguard Capital Wealth Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2019 after selling out during the quarter.
Vanguard Capital Wealth Advisors sold 1,778 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2019, an estimated $220K.
Vanguard Capital Wealth Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2018 and held it in 1 quarter.
Vanguard Capital Wealth Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $220K in Q4 2018.
227 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2019.

Based on Vanguard Capital Wealth Advisors's 13F filing for Q1 2019, filed 29 Apr 2019.